Lindsay A Rosenwald Md bought $1.4M of FBIO
PRESIDENT, CEO & CHAIRMAN at Fortress Biotech, Inc.. 763,359 shares at an average of $1.84, traded Sep 23, 2024, filed Sep 25, 2024.
Score components
- +25RoleCEO
- +25Trade size$1.4M at market
- +6Relative to holdingsHoldings up 26%
- +18Price context9% above the 52-week low; 71% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying5 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +31.2%, 3m +28.4%, 6m +19.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-023957, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 23, 2024 | POpen-market purchase Common stock, par value $0.001 | +763,359 | $1.84 | $1.4M | 3,657,264 | Sep 25, 2024 |
| Sep 23, 2024 | POpen-market purchase Warrants to Purchase Common Stockderivative | +763,359 | $0.13 | $95k | 763,359 | Sep 25, 2024 |
Related signals
Other insiders at Fortress Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 52Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 46Moderate | Fortress Biotech, Inc. | David Jin Chief Financial Officer | $3,750 500 shares | - | |
| 52Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 52Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 47Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $33k 20,000 shares | +1% | |
| 20Weak | FBIOsell Fortress Biotech, Inc. | Dov Klein director | $19k 10,000 shares | -16% | |
| 28Weak | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $18k 10,000 shares | +0% | |
| 48Moderate | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $119k 50,000 shares | +2% | |
| 57Moderate | Fortress Biotech, Inc. | Michael S Weiss See Remarks | $250k 147,058 shares | +15% | |
| 86Strong | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $2.7M 1,567,515 shares | +152% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.